Home » Topics » BioWorld Science

BioWorld Science
RSS

Prevention of neurodegeneration in Parkinson's disease reported

Dec. 22, 1997

Idec's immunotherapy shows promise in phase I/II for non-Hodgkin's lymphoma

Dec. 22, 1997

Vyrex's respiratory antioxidant shows potential as asthma therapy

Dec. 22, 1997

Penederm and Mylan to copromote Mentax

Dec. 22, 1997

Flt3 ligand stimulates production of fully functional dendritic cells

Dec. 22, 1997

Squalamine enters phase I for the treatment of cancer

Dec. 22, 1997

FDA Advisory Committee does not recommend approval for DepoCyt

Dec. 19, 1997

Hemolink enters phase II trials for second indication

Dec. 19, 1997

VIMRx and Baxter form new company focused on cell therapy

Dec. 19, 1997

Nutropin AQ also wins FDA approval

Dec. 19, 1997

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...